Tapewire

Nasdaq · USD

IOVA

IOVANCE BIOTHERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
2090
SEC CIK
0001425205
Parsed reports
251

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 02, 2025 Filed Dec 3, 2025 22:04 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionCommon Stock 3,906 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118170 · tm2532666-4_4seq1.xml · nonDerivative · entry 3

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,640

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 22:01 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 10,417 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · derivative · entry 6

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,418

Underlying: Common stock · 10,417 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 22:01 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Tax withholdingCommon Stock 4,426 $2.14 $9,471.64
Disclosure

SEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · nonDerivative · entry 4

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 464,522

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 22:01 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionCommon Stock 10,417 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · nonDerivative · entry 3

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 468,948

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 22:02 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 3,516 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · derivative · entry 6

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,517

Underlying: Common stock · 3,516 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 22:02 UTC
BILINSKY IGORChief Operating Officer
Tax withholdingCommon Stock 1,786 $2.14 $3,822.04
Disclosure

SEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · nonDerivative · entry 4

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,744

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 22:02 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionCommon Stock 3,516 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · nonDerivative · entry 3

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,530

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:00 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionRestricted Stock Units · Derivative 5,469 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118167 · tm2532666-1_4seq1.xml · derivative · entry 3

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,348

Underlying: Common stock · 5,469 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:00 UTC
Puri Raj K.Chief Regulatory Officer
Tax withholdingCommon Stock 2,467 $2.23 $5,501.41
Disclosure

SEC source: 0001104659-25-118167 · tm2532666-1_4seq1.xml · nonDerivative · entry 2

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,859

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:00 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionCommon Stock 5,469 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118167 · tm2532666-1_4seq1.xml · nonDerivative · entry 1

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,326

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:04 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 8,789 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118170 · tm2532666-4_4seq1.xml · derivative · entry 5

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,949

Underlying: Common stock · 8,789 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:04 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Tax withholdingCommon Stock 4,464 $2.23 $9,954.72
Disclosure

SEC source: 0001104659-25-118170 · tm2532666-4_4seq1.xml · nonDerivative · entry 2

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,734

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:04 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionCommon Stock 8,789 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118170 · tm2532666-4_4seq1.xml · nonDerivative · entry 1

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,198

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:01 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 41,669 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · derivative · entry 5

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 208,344

Underlying: Common stock · 41,669 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:01 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Tax withholdingCommon Stock 17,701 $2.23 $39,473.23
Disclosure

SEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · nonDerivative · entry 2

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 458,531

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:01 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionCommon Stock 41,669 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · nonDerivative · entry 1

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 476,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:02 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 8,789 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · derivative · entry 5

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,949

Underlying: Common stock · 8,789 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:02 UTC
BILINSKY IGORChief Operating Officer
Tax withholdingCommon Stock 4,464 $2.23 $9,954.72
Disclosure

SEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · nonDerivative · entry 2

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,014

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:02 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionCommon Stock 8,789 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · nonDerivative · entry 1

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionRestricted Stock Units · Derivative 5,470 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087547 · tm2525186-3_4seq1.xml · derivative · entry 3

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,817

Underlying: Common stock · 5,470 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
Puri Raj K.Chief Regulatory Officer
Tax withholdingCommon Stock 2,467 $2.19 $5,402.73
Disclosure

SEC source: 0001104659-25-087547 · tm2525186-3_4seq1.xml · nonDerivative · entry 2

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,857

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionCommon Stock 5,470 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087547 · tm2525186-3_4seq1.xml · nonDerivative · entry 1

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,324

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 8,790 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087546 · tm2525186-2_4seq1.xml · derivative · entry 4

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,738

Underlying: Common stock · 8,790 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 3,907 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087546 · tm2525186-2_4seq1.xml · derivative · entry 3

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,813

Underlying: Common stock · 3,907 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Tax withholdingCommon Stock 6,448 $2.19 $14,121.12
Disclosure

SEC source: 0001104659-25-087546 · tm2525186-2_4seq1.xml · nonDerivative · entry 2

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,409

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionCommon Stock 12,697 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087546 · tm2525186-2_4seq1.xml · nonDerivative · entry 1

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:35 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 41,669 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087549 · tm2525186-4_4seq1.xml · derivative · entry 4

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,013

Underlying: Common stock · 41,669 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:35 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 10,417 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087549 · tm2525186-4_4seq1.xml · derivative · entry 3

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,385

Underlying: Common stock · 10,417 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:35 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Tax withholdingCommon Stock 22,127 $2.19 $48,458.13
Disclosure

SEC source: 0001104659-25-087549 · tm2525186-4_4seq1.xml · nonDerivative · entry 2

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 434,563

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:35 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionCommon Stock 52,086 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087549 · tm2525186-4_4seq1.xml · nonDerivative · entry 1

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 456,690

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 8,790 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087545 · tm2525186-1_4seq1.xml · derivative · entry 4

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,738

Underlying: Common stock · 8,790 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 3,516 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087545 · tm2525186-1_4seq1.xml · derivative · entry 3

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,033

Underlying: Common stock · 3,516 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
BILINSKY IGORChief Operating Officer
Tax withholdingCommon Stock 6,250 $2.19 $13,687.50
Disclosure

SEC source: 0001104659-25-087545 · tm2525186-1_4seq1.xml · nonDerivative · entry 2

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,689

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:30 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionCommon Stock 12,306 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-087545 · tm2525186-1_4seq1.xml · nonDerivative · entry 1

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,939

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
August 06, 2025 Filed Aug 8, 2025 20:06 UTC
Roche Corleen M.Chief Financial Officer
GrantRestricted Stock Units · Derivative 150,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-075687 · tm2522878-2_4seq1.xml · derivative · entry 2

Roche Corleen M. · CIK 0001857905 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common stock · 150,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

F1 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

Read SEC document
August 06, 2025 Filed Aug 8, 2025 20:06 UTC
Roche Corleen M.Chief Financial Officer
GrantStock Option (right to buy) · Derivative 300,000 $0.00 Strike: $2.58 $0.00
Disclosure

SEC source: 0001104659-25-075687 · tm2522878-2_4seq1.xml · derivative · entry 1

Roche Corleen M. · CIK 0001857905 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common stock · 300,000 shares

Expires 2035-08-06

F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:05 UTC GrantDeferred Restricted Stock Unit · Derivative 67,546 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-060245 · tm2518181-1_4seq1.xml · derivative · entry 1

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,546

Underlying: Common Stock · 67,546 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:09 UTC GrantDeferred Restricted Stock Unit · Derivative 67,546 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-060254 · tm2518181-5_4seq1.xml · derivative · entry 1

Countouriotis Athena · CIK 0001571469 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,546

Underlying: Common Stock · 67,546 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:08 UTC GrantDeferred Restricted Stock Unit · Derivative 67,546 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-060253 · tm2518181-4_4seq1.xml · derivative · entry 1

Maynard Ryan D · CIK 0001363984 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,546

Underlying: Common Stock · 67,546 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:07 UTC GrantDeferred Restricted Stock Unit · Derivative 67,546 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-060251 · tm2518181-3_4seq1.xml · derivative · entry 1

WEISER MICHAEL · CIK 0001221449 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,546

Underlying: Common Stock · 67,546 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:06 UTC GrantDeferred Restricted Stock Unit · Derivative 135,092 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-060249 · tm2518181-2_4seq1.xml · derivative · entry 1

Dukes Iain D. · CIK 0001681955 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,092

Underlying: Common Stock · 135,092 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:05 UTC
Kirby Daniel GordonChief Commercial Officer
PurchaseCommon Stock 30,000 $1.84 $55,200.00
Disclosure

SEC source: 0001104659-25-057310 · tm2517335-1_4seq1.xml · nonDerivative · entry 1

Kirby Daniel Gordon · CIK 0002055001 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · shares: Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:51 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionRestricted Stock Units · Derivative 5,469 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-056444 · tm2517077-5_4seq1.xml · derivative · entry 3

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,287

Underlying: Common Stock · 5,469 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:51 UTC
Puri Raj K.Chief Regulatory Officer
Tax withholdingCommon Stock 2,467 $1.76 $4,341.92
Disclosure

SEC source: 0001104659-25-056444 · tm2517077-5_4seq1.xml · nonDerivative · entry 2

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,854

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:51 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionCommon Stock 5,469 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-056444 · tm2517077-5_4seq1.xml · nonDerivative · entry 1

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,321

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:49 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 8,789 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-056438 · tm2517077-3_4seq1.xml · derivative · entry 4

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,528

Underlying: Common stock · 8,789 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:49 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 3,906 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-056438 · tm2517077-3_4seq1.xml · derivative · entry 3

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,720

Underlying: Common stock · 3,906 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:49 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Tax withholdingCommon Stock 6,448 $1.76 $11,348.48
Disclosure

SEC source: 0001104659-25-056438 · tm2517077-3_4seq1.xml · nonDerivative · entry 2

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,160

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:49 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionCommon Stock 12,695 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-056438 · tm2517077-3_4seq1.xml · nonDerivative · entry 1

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,608

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:50 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 41,668 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-056440 · tm2517077-4_4seq1.xml · derivative · entry 4

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,682

Underlying: Common stock · 41,668 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.